{
  "entities": [
    { "id": 1, "text": "major depressive disorder", "type": "medical_condition" },
    { "id": 2, "text": "depression", "type": "medical_condition" },
    { "id": 3, "text": "selective serotonin reuptake inhibitors", "type": "medication" },
    { "id": 4, "text": "SSRIs", "type": "medication" },
    { "id": 5, "text": "pharmacotherapy", "type": "treatment_type" },
    { "id": 6, "text": "psychotherapy", "type": "treatment_type" },
    { "id": 7, "text": "electroconvulsive therapy", "type": "treatment_type" },
    { "id": 8, "text": "somatic therapies", "type": "treatment_type" },
    { "id": 9, "text": "remission", "type": "outcome" },
    { "id": 10, "text": "relapses", "type": "outcome" },
    { "id": 11, "text": "side effects", "type": "outcome" },
    { "id": 12, "text": "dropout", "type": "outcome" },
    { "id": 13, "text": "monoamine oxidase inhibitors", "type": "medication" },
    { "id": 14, "text": "MAOIs", "type": "medication" },
    { "id": 15, "text": "tricyclic antidepressants", "type": "medication" },
    { "id": 16, "text": "TCAs", "type": "medication" },
    { "id": 17, "text": "serotonin-norepinephrine reuptake inhibitors", "type": "medication" },
    { "id": 18, "text": "SNRIs", "type": "medication" },
    { "id": 19, "text": "venlafaxine", "type": "medication" },
    { "id": 20, "text": "duloxetine", "type": "medication" },
    { "id": 21, "text": "reboxetine", "type": "medication" },
    { "id": 22, "text": "trazodone", "type": "medication" },
    { "id": 23, "text": "nefazodone", "type": "medication" },
    { "id": 24, "text": "bupropion", "type": "medication" },
    { "id": 25, "text": "mirtazapine", "type": "medication" },
    { "id": 26, "text": "vortioxetine", "type": "medication" },
    { "id": 27, "text": "vilazodone", "type": "medication" },
    { "id": 28, "text": "ketamine", "type": "medication" },
    { "id": 29, "text": "esketamine", "type": "medication" },
    { "id": 30, "text": "Hamilton Depression Rating Scale (HDRS)", "type": "measure" },
    { "id": 31, "text": "Cognitive-behavioral therapy", "type": "treatment_type" },
    { "id": 32, "text": "CBT", "type": "treatment_type" },
    { "id": 33, "text": "interpersonal therapy", "type": "treatment_type" },
    { "id": 34, "text": "IPT", "type": "treatment_type" },
    { "id": 35, "text": "supportive therapy", "type": "treatment_type" },
    { "id": 36, "text": "psychoeducational intervention", "type": "treatment_type" },
    { "id": 37, "text": "mindfulness-based cognitive therapy", "type": "treatment_type" },
    { "id": 38, "text": "MBCT", "type": "treatment_type" },
    { "id": 39, "text": "Cognitive Behavioral Analysis System of Psychotherapy", "type": "treatment_type" },
    { "id": 40, "text": "CBASP", "type": "treatment_type" },
    { "id": 41, "text": "problem-solving therapy", "type": "treatment_type" },
    { "id": 42, "text": "PST", "type": "treatment_type" },
    { "id": 43, "text": "marital and family therapy", "type": "treatment_type" },
    { "id": 44, "text": "MFT", "type": "treatment_type" },
    { "id": 45, "text": "psychodynamic therapy", "type": "treatment_type" },
    { "id": 46, "text": "group therapy", "type": "treatment_type" },
    { "id": 47, "text": "physical exercise", "type": "treatment_type" },
    { "id": 48, "text": "repetitive transcranial magnetic stimulation", "type": "treatment_type" },
    { "id": 49, "text": "rTMS", "type": "treatment_type" },
    { "id": 50, "text": "transcranial direct current stimulation", "type": "treatment_type" },
    { "id": 51, "text": "tDCS", "type": "treatment_type" },
    { "id": 52, "text": "vagus nerve stimulation", "type": "treatment_type" },
    { "id": 53, "text": "VNS", "type": "treatment_type" },
    { "id": 54, "text": "deep brain stimulation", "type": "treatment_type" },
    { "id": 55, "text": "DBS", "type": "treatment_type" },
    { "id": 56, "text": "magnetic seizure therapy", "type": "treatment_type" },
    { "id": 57, "text": "phototherapy", "type": "treatment_type" },
    { "id": 58, "text": "adolescents", "type": "patient_group" },
    { "id": 59, "text": "elderly", "type": "patient_group" },
    { "id": 60, "text": "children", "type": "patient_group" },
    { "id": 61, "text": "outpatients", "type": "patient_group" },
    { "id": 62, "text": "hospitalized patients", "type": "patient_group" },
    { "id": 63, "text": "patients with severe major depressive disorder symptoms", "type": "patient_group" },
    { "id": 64, "text": "patients with chronic depression", "type": "patient_group" },
    { "id": 65, "text": "patients with resistant depression", "type": "patient_group" },
    { "id": 66, "text": "patients with psychotic depression", "type": "patient_group" },
    { "id": 67, "text": "pregnant patients", "type": "patient_group" },
    { "id": 68, "text": "patients with Parkinson’s disease", "type": "patient_group" },
    { "id": 69, "text": "STAR*D", "type": "study" }
  ],
  "relationships": [
    { "head": 3, "tail": 2, "type": "treats", "evidence": "Pharmacotherapy, especially selective serotonin reuptake inhibitors antidepressants, remains the most frequent option for treating depression during the acute phase" },
    { "head": 4, "tail": 2, "type": "treats", "evidence": "SSRIs remain the gold-standard treatment for depression" },
    { "head": 5, "tail": 2, "type": "treats", "evidence": "Acute-phase treatment options include pharmacotherapy" },
    { "head": 6, "tail": 2, "type": "treats", "evidence": "Depression-focused psychotherapy is the second most common option for helping patients overcome the acute phase, maintain remission, and prevent relapses" },
    { "head": 7, "tail": 2, "type": "treats", "evidence": "Electroconvulsive therapy is the most effective somatic therapy for depression in some specific situations" },
    { "head": 8, "tail": 2, "type": "treats", "evidence": "somatic therapies such as electroconvulsive therapy (ECT)" },
    { "head": 13, "tail": 2, "type": "treats", "evidence": "Iproniazid was the first drug defined as an antidepressant; it was later classified as a monoamine oxidase inhibitor (MAOI)" },
    { "head": 14, "tail": 2, "type": "treats", "evidence": "MAOIs have demonstrated specific efficacy in treating depression with atypical features" },
    { "head": 15, "tail": 2, "type": "treats", "evidence": "TCAs...are about as effective as other classes of antidepressants...in treating major depression" },
    { "head": 16, "tail": 2, "type": "treats", "evidence": "TCAs...are about as effective as other classes of antidepressants...in treating major depression" },
    { "head": 17, "tail": 2, "type": "treats", "evidence": "Other monoamine...reuptake inhibitors called SNRIs emerged during the 1990s" },
    { "head": 18, "tail": 2, "type": "treats", "evidence": "Currently available SNRIs are venlafaxine, desvenlafaxine...and duloxetine" },
    { "head": 19, "tail": 2, "type": "treats", "evidence": "venlafaxine and duloxetine are generally considered effective as SSRIs" },
    { "head": 20, "tail": 2, "type": "treats", "evidence": "venlafaxine and duloxetine are generally considered effective as SSRIs" },
    { "head": 21, "tail": 2, "type": "treats", "evidence": "reboxetine...seems less efficacious than SSRIs" },
    { "head": 22, "tail": 2, "type": "treats", "evidence": "Trazodone...has been shown to be an effective antidepressant in placebo-controlled research" },
    { "head": 23, "tail": 2, "type": "treats", "evidence": "Nefazodone’s...efficacy and overall tolerability are comparable to those of SSRIs" },
    { "head": 24, "tail": 2, "type": "treats", "evidence": "bupropion...efficacy of bupropion in treating MDD is comparable to that of SSRIs" },
    { "head": 25, "tail": 2, "type": "treats", "evidence": "Mirtazapine is about as effective as SSRIs" },
    { "head": 26, "tail": 2, "type": "treats", "evidence": "vortioxetine is a very recent antidepressant...seems to indicate a level of efficacy to other antidepressants" },
    { "head": 27, "tail": 2, "type": "treats", "evidence": "vilazodone...appear to produce less sexual dysfunction" },
    { "head": 28, "tail": 2, "type": "treats", "evidence": "ketamine has very quick effects on resistant unipolar (and, possibly, bipolar) depression" },
    { "head": 29, "tail": 2, "type": "treats", "evidence": "esketamine...was approved...for treatment-resistant depression" },
    { "head": 31, "tail": 2, "type": "treats", "evidence": "CBT is one of the most well-documented and validated psychotherapeutic methods available...CBT is a well-known effective treatment method for MDD" },
    { "head": 32, "tail": 2, "type": "treats", "evidence": "CBT is a well-known effective treatment method for MDD" },
    { "head": 33, "tail": 2, "type": "treats", "evidence": "IPT, like CBT, is a first-line treatment for mild to moderate major depressive episodes in adults" },
    { "head": 34, "tail": 2, "type": "treats", "evidence": "IPT, like CBT, is a first-line treatment for mild to moderate major depressive episodes in adults" },
    { "head": 35, "tail": 2, "type": "treats", "evidence": "ST is not as well-structured or well-evaluated as CBT or IPT, it is still commonly used to support depressed patients" },
    { "head": 36, "tail": 2, "type": "treats", "evidence": "Psycho-education...educates depressed patients...about depression symptoms and management" },
    { "head": 37, "tail": 2, "type": "treats", "evidence": "MBCT...reduces relapse...a potential alternative to reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence" },
    { "head": 38, "tail": 2, "type": "treats", "evidence": "MBCT...reduces relapse" },
    { "head": 39, "tail": 2, "type": "treats", "evidence": "CBASP for treating chronic depression" },
    { "head": 40, "tail": 2, "type": "treats", "evidence": "CBASP for treating chronic depression" },
    { "head": 41, "tail": 2, "type": "treats", "evidence": "PST has been used in different clinical situations, like preventing depression among the elderly and treating patients with mild depressive symptoms" },
    { "head": 42, "tail": 2, "type": "treats", "evidence": "PST has been used in different clinical situations, like preventing depression among the elderly and treating patients with mild depressive symptoms" },
    { "head": 43, "tail": 2, "type": "treats", "evidence": "Marital and family therapy (MFT) is effective in treating some aspects of depression" },
    { "head": 44, "tail": 2, "type": "treats", "evidence": "Marital and family therapy (MFT) is effective in treating some aspects of depression" },
    { "head": 45, "tail": 2, "type": "treats", "evidence": "Psychodynamic therapy’s efficacy in the acute phase of MDD is well-established compared to other forms of psychotherapy" },
    { "head": 46, "tail": 2, "type": "treats", "evidence": "Group therapy...data support the efficacy of specific types of GT inspired by CBT and IPT" },
    { "head": 47, "tail": 2, "type": "treats", "evidence": "depressed patients perform regular physical activity to alleviate symptoms and prevent relapses" },
    { "head": 48, "tail": 2, "type": "treats", "evidence": "rTMS...has been widely used in research on depression" },
    { "head": 49, "tail": 2, "type": "treats", "evidence": "rTMS...has been widely used in research on depression" },
    { "head": 50, "tail": 2, "type": "treats", "evidence": "tDCS...can be used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients" },
    { "head": 51, "tail": 2, "type": "treats", "evidence": "tDCS...can be used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients" },
    { "head": 52, "tail": 2, "type": "treats", "evidence": "VNS is a therapeutic method that has been used...to treat resistant unilateral or bipolar depression" },
    { "head": 53, "tail": 2, "type": "treats", "evidence": "VNS is a therapeutic method that has been used...to treat resistant unilateral or bipolar depression" },
    { "head": 54, "tail": 2, "type": "treats", "evidence": "DBS of the subgenual cingulate white matter...elicited a clinical response in 60% of resistant depression patients" },
    { "head": 55, "tail": 2, "type": "treats", "evidence": "DBS of the subgenual cingulate white matter...elicited a clinical response in 60% of resistant depression patients" },
    { "head": 56, "tail": 2, "type": "treats", "evidence": "Magnetic seizure therapy...is still being investigated as a viable alternative to ECT to treat many psychiatric disorders" },
    { "head": 57, "tail": 2, "type": "treats", "evidence": "phototherapy...treatment method is effective both for those with seasonal and non-seasonal depression" },
    { "head": 4, "tail": 9, "type": "has_outcome", "evidence": "Treatment during the acute phase of a major depressive episode aims to help the patient reach a remission state" },
    { "head": 4, "tail": 11, "type": "has_outcome", "evidence": "SSRIs...causing fewer adverse effects" },
    { "head": 4, "tail": 12, "type": "has_outcome", "evidence": "citalopram, escitalopram, fluoxetine, sertraline, and vortioxetine have been deemed more tolerable than other antidepressants, whereas amitriptyline, clomipramine, duloxetine, fluvoxamine, trazodone, and venlafaxine had the highest dropout rates" },
    { "head": 4, "tail": 10, "type": "has_outcome", "evidence": "Depression-focused psychotherapy is the second most common option for helping patients...prevent relapses" },
    { "head": 31, "tail": 9, "type": "has_outcome", "evidence": "CBT...has been recommended in most guidelines as a first-line treatment" },
    { "head": 31, "tail": 10, "type": "has_outcome", "evidence": "After remission, CBT...are proposed to maintain and prevent depression" },
    { "head": 37, "tail": 10, "type": "has_outcome", "evidence": "MBCT treatment during remission reduces relapse" },
    { "head": 47, "tail": 10, "type": "has_outcome", "evidence": "depressed patients perform regular physical activity to alleviate symptoms and prevent relapses" },
    { "head": 7, "tail": 9, "type": "has_outcome", "evidence": "ECT reduces the number of hospital readmissions and lightens the burden of depression, leading to a better quality of life" },
    { "head": 7, "tail": 10, "type": "has_outcome", "evidence": "The maintenance ECT also appears to prevent relapses" },
    { "head": 7, "tail": 11, "type": "has_outcome", "evidence": "ECT is considered safe" },
    { "head": 48, "tail": 9, "type": "has_outcome", "evidence": "rTMS...significant difference...regarding its improvements in depressive symptoms" },
    { "head": 50, "tail": 9, "type": "has_outcome", "evidence": "tDCS technique significantly outperforms the simulator in terms of the rate of response and remission" },
    { "head": 50, "tail": 10, "type": "has_outcome", "evidence": "The antidepressant effects of tDCS may involve long-term neuroplastic changes that continue to occur even after the acute phase of treatment, which explains its delayed efficacy" },
    { "head": 52, "tail": 9, "type": "has_outcome", "evidence": "VNS has demonstrated progressively increasing improvements in depressive symptoms, with significant positive outcomes observed after six to 12 mo; these benefits can last for up to two years" },
    { "head": 54, "tail": 9, "type": "has_outcome", "evidence": "DBS...elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients" },
    { "head": 56, "tail": 11, "type": "has_outcome", "evidence": "magnetic seizure therapy...appears to induce fewer neurocognitive effects than ECT" },
    { "head": 58, "tail": 31, "type": "affects", "evidence": "In adolescent patients with depression, CBT is also a recommended option with plenty of evidence from multiple trials" },
    { "head": 59, "tail": 31, "type": "affects", "evidence": "CBT is also a promising option for elderly depressed patients, though substantial evidence is still lacking" },
    { "head": 60, "tail": 31, "type": "affects", "evidence": "CBT...remains the first-line treatment in children despite mixed findings across trials" },
    { "head": 62, "tail": 15, "type": "affects", "evidence": "some TCAs can be more effective than SSRIs when used to treat hospitalized patients" },
    { "head": 61, "tail": 4, "type": "affects", "evidence": "no differences have been detected in outpatients who are considered less severely ill" },
    { "head": 63, "tail": 15, "type": "affects", "evidence": "superiority of TCAs over SSRIs for patients with severe major depressive disorder (MDD) symptoms who require hospitalization" },
    { "head": 64, "tail": 39, "type": "affects", "evidence": "CBASP for treating chronic depression" },
    { "head": 65, "tail": 7, "type": "affects", "evidence": "ECT is the most well-known treatment for resistant depression" },
    { "head": 65, "tail": 28, "type": "affects", "evidence": "ketamine has very quick effects on resistant unipolar (and, possibly, bipolar) depression" },
    { "head": 66, "tail": 7, "type": "affects", "evidence": "ECT is typically recommended for patients with severe and psychotic depression" },
    { "head": 67, "tail": 7, "type": "affects", "evidence": "ECT is typically recommended for...pregnant patients" },
    { "head": 68, "tail": 7, "type": "affects", "evidence": "ECT is typically recommended for...patients with Parkinson’s disease" },
    { "head": 69, "tail": 13, "type": "compares", "evidence": "Tranylcypromine vs venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report" },
    { "head": 69, "tail": 19, "type": "compares", "evidence": "Tranylcypromine vs venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report" },
    { "head": 69, "tail": 25, "type": "compares", "evidence": "Tranylcypromine vs venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report" }
  ]
}